Synergistic effect of acetylcholinesterase inhibition (donepezil) and 5-HT4 receptor activation (RS67333) on object recognition in mice

This publication has 39 references indexed in Scilit:

• Cerebral Serotonin 4 Receptors and Amyloid-β in Early Alzheimer's Disease
  Journal of Alzheimer’s Disease, 2011
• 5-HT4 receptors, a place in the sun: act two
  Current Opinion in Pharmacology, 2011
• Current perspectives on pharmacotherapy of Alzheimer's disease
  Expert Opinion on Pharmacotherapy, 2011
• Combination treatments in Alzheimer’s disease: risks and benefits
  Expert Review of Neurotherapeutics, 2010
• Design, Synthesis, and Biological Evaluation of New 5-HT₄ Receptor Agonists: Application as Amyloid Cascade Modulators and Potential Therapeutic Utility in Alzheimer’s Disease
  Journal of Medicinal Chemistry, 2009
• Does Serotonin Augmentation Have Any Effect on Cognition and Activities of Daily Living in Alzheimer's Dementia?
  Journal of Clinical Psychopharmacology, 2007
• 5-HT4 receptor and Alzheimer's disease: The amyloid connection
  Experimental Neurology, 2007
• Rationale for Combination Therapy With Galantamine and Memantine in Alzheimer's Disease
  The Journal of Clinical Pharmacology, 2006
• SL65.0155, A Novel 5-Hydroxytryptamine4 Receptor Partial Agonist with Potent Cognition-Enhancing Properties
  The Journal of Pharmacology and Experimental Therapeutics, 2002
• Molecular, pharmacological and functional diversity of 5-HT receptors
  Pharmacology Biochemistry and Behavior, 2002